logo

Zimmer Biomet – Hot or Not

PUBLISHED: Fri, 18 Aug 2017 05:01:30 GMT

Share


Zimmer Biomet designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products. It has a market cap of $ 22.8billion. Has a PE of 32.27, dividend yield of 0.85 per cent. Guest Nicholas Sorour, Sasfin Wealth and resident expert Paul Theron from Vestact decide whether Zimmer Biomet hot or not.


Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.

RELATED